Eli Lilly & Co. (LLY)
987.05
-1.82
(-0.18%)
USD |
NYSE |
May 06, 16:00
985.23
-1.82
(-0.18%)
Pre-Market: 06:01
Eli Lilly SG&A Expense (TTM) : 11.56B for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Viking Therapeutics, Inc. | 48.28M |
| Apellis Pharmaceuticals, Inc. | 550.26M |
| Arcellx, Inc. | 117.76M |
| Moderna, Inc. | 979.00M |